(Q74179989)
Statements
Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization (English)
E J Topol
1 reference
D J Kereiakes
A M Lincoff
E S Barnathan
M A Mascelli
L I Deckelbaum
K K Patel
B Frederick